360 related articles for article (PubMed ID: 26739947)
1. Topical application of timolol decreases the severity and frequency of epistaxis in patients who have previously undergone nasal dermoplasty for hereditary hemorrhagic telangiectasia.
Ichimura K; Kikuchi H; Imayoshi S; Dias MS
Auris Nasus Larynx; 2016 Aug; 43(4):429-32. PubMed ID: 26739947
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial.
Peterson AM; Lee JJ; Kallogjeri D; Schneider JS; Chakinala MM; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1006-1014. PubMed ID: 32940653
[TBL] [Abstract][Full Text] [Related]
3. TIMolol nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT) - Study protocol of the prospective, randomized, double-blind, controlled cross-over TIM-HHT trial.
Andorfer KEC; Seebauer CT; Koller M; Zeman F; Berneburg M; Fischer R; Vielsmeier V; Bohr C; Kühnel TS
Clin Hemorheol Microcirc; 2022; 80(3):307-315. PubMed ID: 34864649
[TBL] [Abstract][Full Text] [Related]
4. [Clinical 22-case study of hereditary hemorrhagic telangiectasia subjects undergoing nasal dermoplasty].
Kikuchi H; Imayoshi S; Yamauchi T; Ichimura K
Nihon Jibiinkoka Gakkai Kaiho; 2012 Feb; 115(2):108-11. PubMed ID: 22568130
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial.
Dupuis-Girod S; Pitiot V; Bergerot C; Fargeton AE; Beaudoin M; Decullier E; Bréant V; Colombet B; Philouze P; Faure F; Letievant JC
Sci Rep; 2019 Aug; 9(1):11986. PubMed ID: 31427745
[TBL] [Abstract][Full Text] [Related]
6. Intranasal topical estrogen in the management of epistaxis in hereditary hemorrhagic telangiectasia.
Minami K; Haji T
Acta Otolaryngol; 2016; 136(5):528-31. PubMed ID: 26808464
[TBL] [Abstract][Full Text] [Related]
7. Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients.
Pagella F; Colombo A; Matti E; Giourgos G; Tinelli C; Olivieri C; Danesino C
Am J Rhinol Allergy; 2009; 23(1):52-8. PubMed ID: 19379613
[TBL] [Abstract][Full Text] [Related]
8. The Use of Beta-Blockers in Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review.
Albarki H; Rimmer J
Am J Rhinol Allergy; 2022 Nov; 36(6):890-896. PubMed ID: 35929049
[TBL] [Abstract][Full Text] [Related]
9. [Nasal cavity dermoplasty as a treatment of recurrent bleeding in Rendu-Osler-Weber's disease].
Kłos A; Golqbek W; Morshed K
Otolaryngol Pol; 2007; 61(1):74-9. PubMed ID: 17605423
[TBL] [Abstract][Full Text] [Related]
10. Free-flap reconstruction for the management of life-threatening hereditary hemorrhagic telangiectasia.
Choi JW; Joo YH; Jeong WS; Jang YJ
Auris Nasus Larynx; 2017 Oct; 44(5):607-611. PubMed ID: 27616747
[TBL] [Abstract][Full Text] [Related]
11. Nasal dermoplasty for Japanese hereditary hemorrhagic telangiectasia.
Ichimura K; Tanaka H; Yamamoto Y; Nakamura K
Auris Nasus Larynx; 2006 Dec; 33(4):423-8. PubMed ID: 16707240
[TBL] [Abstract][Full Text] [Related]
12. Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.
Fiorella ML; Ross D; Henderson KJ; White RI
Laryngoscope; 2005 Feb; 115(2):301-5. PubMed ID: 15689755
[TBL] [Abstract][Full Text] [Related]
13. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.
Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR
JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329
[TBL] [Abstract][Full Text] [Related]
14. Long-term complications of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.
Levine CG; Ross DA; Henderson KJ; Leder SB; White RI
Otolaryngol Head Neck Surg; 2008 Jun; 138(6):721-4. PubMed ID: 18503842
[TBL] [Abstract][Full Text] [Related]
15. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia.
Mahoney EJ; Shapshay SM
Am J Rhinol; 2006; 20(1):87-90. PubMed ID: 16539301
[TBL] [Abstract][Full Text] [Related]
16. Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia - a preliminary report.
Mei-Zahav M; Blau H; Bruckheimer E; Zur E; Goldschmidt N
J Otolaryngol Head Neck Surg; 2017 Oct; 46(1):58. PubMed ID: 28978360
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose.
Dheyauldeen S; Østertun Geirdal A; Osnes T; Vartdal LS; Dollner R
Laryngoscope; 2012 Jun; 122(6):1210-4. PubMed ID: 22565282
[TBL] [Abstract][Full Text] [Related]
18. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia.
Hitchings AE; Lennox PA; Lund VJ; Howard DJ
Am J Rhinol; 2005; 19(1):75-8. PubMed ID: 15794079
[TBL] [Abstract][Full Text] [Related]
19. Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia.
Sena Esteves S; Cardoso C; Silva A; Abrunhosa J; Almeida E Sousa C
Acta Otorrinolaringol Esp; 2016; 67(6):345-348. PubMed ID: 27079134
[TBL] [Abstract][Full Text] [Related]
20. Influence of temporary nasal occlusion (tNO) on epistaxis frequency in patients with hereditary hemorrhagic telangiectasia (HHT).
Wirsching KEC; Haubner F; Kühnel TS
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1891-1896. PubMed ID: 28070641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
